Ocuphire Pharma, Inc. Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Summary Of Stock Compensation Expense) (Details)

Stock-Based Compensation (Summary Of Stock Compensation Expense) (Details) (USD $)	3 Months Ended		144 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share Based Compensation	$ 371,951	$ 91,174	$ 6,180,567
Payroll [Member] \| General And Administrative [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share Based Compensation	350,379	39,317	2,971,808
Payroll [Member] \| Research And Development [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share Based Compensation	15,732	20,498	1,063,789
Consulting and other professional fees [Member] \| General And Administrative [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share Based Compensation	3,893	23,222	814,348
Consulting and other professional fees [Member] \| Research And Development [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share Based Compensation	$ 1,947	$ 8,137	$ 1,330,622

- Definition

Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.

+ References + Details